Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 749 OA Comments

749 OA Comments

posted on Mar 06, 2009 03:51AM

Actually the OA rejection is good news to me. Firstly, it focuses on only 2 pieces of prior art, and discounts all the others as improper or duplicative.

Good news becuase the primary rejection is the Koopman patent. Koopman and the patent are quite familiar to Moore. They are both referenced on his Site. If Koopman is not a problem, unlikely May will be. All IMHO Opty

http://www.ultratechnology.com/cowbo...

Share
New Message
Please login to post a reply